Date: Thursday, 4 December 2025
Time: 17:00 (CET)
First Webinar
Date: Tuesday, 2 December 2025
Time: 12:30 – 13:30 CET
17:00 – 18:00 CET
(Two time slots – same content)
JHTA 2025 will take place in Marseille, 10–11 December 2025.
INNOVATIONS IN CARDIOMETABOLIC MANAGEMENT
January 16 – Abstract Submission Final Deadline (NO DEADLINE EXTENSION)
February 16 – Late Breaker Submission Opens
February 27 – Late Breaker Final Submission
March 3 – Early Bird Registration (DEADLINE)
Date: 6-11 September, 2026
Venue: Lunteren, The Netherlands
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension. Endorsed by the European Federation of Internal Medicine (EFIM), European Renal Association (ERA), and International Society of Hypertension (ISH)
The ESH 2024 Clinical Practice Guidelines provide a novel concise format that supports the dissemination of the most important information of the Guidelines for the management and its implementation into clinical practice.
World Adherence Day is a global initiative committed to empowering individuals to stay on course with their treatment plans and make sustainable, healthy lifestyle choices.
As part of this commitment, ESH is pleased to present a special series of podcasts focused on adherence, offering expert insights and practical guidance to support patients and healthcare professionals.
ESH is pleased to invite you to attend the following upcoming online educational events.
Don’t miss this opportunity to gain invaluable insights from leading hypertension experts and discover practical strategies for improving patient care.
ESH Webinar – Tuesday, 2 December 2025
Translating Guidelines into Practice
ESH Hybrid Webinar 2025 – Thursday, 4 December 2025
Integrative Management of Cardiovascular Disease: A Cardiometabolic Perspective
ESH CKD Real-World-Evidence Research:
“Deficits in CKD screening and management in European patients with hypertension–A call to action”
In 2024, the ESH conducted a survey among its Excellence Centres on CKD management in hypertensive patients. Our research has identified several gaps in CKD management, prompting us to issue a Call to Action to address these critical issues.